SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is drawing attention amid volatile pre-earnings trading, with traders weighing expectations for Q3 results and possible guidance against a broader selloff in AI and growth stocks tied to inflation and interest-rate concerns. Bulls point to data-center power demand and deals involving AEP, Google and Oracle, while bears question the stocks valuation and warn of further downside or a sell-the-news reaction.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARAs prolonged selloff and repeated underperformanceeven as Bitcoin has held up or reboundedare driving discussion. Traders largely blame skepticism about the AI/data-center pivot without signed tenant leases and concerns over finances and management, while some see the decline as overdone and anticipate a rebound if Bitcoin strengthens or a deal emerges.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances ESMO data on lifileucel is driving attention, especially the mature frontline melanoma results with pembrolizumab and preliminary activity in sarcoma. Many traders view the melanoma response and durability findings as supportive of expansion potential, while others note the small cohorts and that the results do not establish success in the still-blinded Phase 3 TILVANCE-301 trial.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Attention is focused on ARKGs reported increase in its ARCT share count, which initially prompted speculation about a major buy. Traders are debating whether the figures reflect a typo or routine ETF share-creation mechanics rather than a deliberate ARK decision to increase its position.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVies run to fresh highs is drawing attention amid a rotation into defensive healthcare stocks, with traders highlighting breakout momentum while some caution that the shares look overextended. Positive Crohns disease and oncology pipeline updates are also part of the discussion, alongside speculation about AbbVie as a potential biotech acquirer.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

A sharp AMP price and volume surge has traders focused on a possible technical breakout, with some speculating that undisclosed news or buying is behind the move. Others warn it may be another short-lived pump, citing AMPs history of fading gains and the lack of a confirmed catalyst.

Aventus Network

AVT is drawing attention amid a volatile rebound, with traders watching rising activity and a thin order book for signs of a breakout. Aventus Clouds decentralized-compute updates add to the bullish narrative, while others point to selling pressure, concentrated ownership, and supply concerns as risks to sustaining momentum.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers steady climb toward a 52-week high has traders focused on whether it can break through the psychologically important $30 level; bullish posts point to call activity, pipeline progress and demand for defensive, dividend-paying stocks, while others expect resistance or a range-bound move. No single catalyst dominates the discussion.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet shares are under pressure amid a broader tech selloff and concerns about macro conditions, with traders debating whether the weakness reflects market-wide moves or company-specific worries about AI competition and spending. The community is split between dip-buyers watching technical support and bears focused on persistent selling, with upcoming earnings seen as a key test for cloud growth and AI execution.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicor is drawing attention after a steep pullback despite two recent Q3 revenue outlook increases, which the company attributed to royalties from its Vertical Power Delivery technology licensing. Traders are divided between buying the weakness ahead of the earnings report and worrying that the selloff reflects fading momentum, profit-taking, or broader pressure on tech stocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Current Price	$21.07
Prev Close	$21.38
Open	$21.07
Dividend Yield	N/A
50-Day Moving Average	$21.74
Beta	N/A
Avg. Volume	310.81
PE Ratio	N/A

52-Week High	$23.54
52-Week Low	$19.90
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

VXM.U.TSX Fundamentals